Surfing the web retrieved these selected informational items:

• Philip W. Kantoff, MD will be joining MSK. Dr. Kantoff was named Chairman of the Department of Medicine and succeeds George J. Bosl, MD who served in this role since 1997.
• Check out Lorenz Studer’s profile in the December 1 issue of “The Scientist” and learn about his research interests and what makes him tick! Dr. Studer is the Director, Center for Stem Cell Biology at MSK.
• MSK’s partnership with Miracle on Madison – just in time for the holiday season.

Surfing the Web uncovered these news items worth sharing:

• New gene-editing technique treats baby’s leukemia. Dr. Renier Brentjens, Director, Cellular Therapeutics from MSK is quoted.
• Meet PAVS (Peyton’s Awesome Virtual Self) – this iPad on wheels is making it possible for a child with cancer to attend school.
• AARC in partnership with MSK and other cancer centers launches data-sharing project for cancer genomic research. Introducing Project GENIE (Genomics Evidence Neoplasia Information Exchange).
• Listen to former MSK physician-in-chief, Dr. Vincent DeVita discuss advancements in the treatment and the ongoing war on cancer. Fresh Air podcast (28:40 min).
• West Cancer Center launches annual oncology conference which will feature speakers from leading cancer institutions. Conference will take place November 13 & 14, 2015.
• New Immunotherapy for Mesothelioma Relies on Altered T-Cells. Dr. Prasad Adusumilli, Deputy Chief, Thoracic Service is quoted.

While browsing the news, these are some of the stories that rose to the top!

• Congratulations to the winner of Revlon’s LOVE IS ON Million Dollar Challenge – “Cycle for Survival” team from Memorial Sloan Kettering (MSK) raised over $950,000 that will go to support women’s cancer, heart disease and diabetes.  Dr. Craig Thompson, MSK’s President and CEO is quoted.

• SELLAS Life Sciences Group (SELLAS), a development-stage biopharmaceutical company focused on innovative products to treat cancers and central nervous system diseases, recently announced that it has appointed to its Scientific Advisory Board – Larry W. Kwak, MD, PhD, of the City of Hope National Medical Center, and Jedd D. Wolchok, MD, PhD, of MSK.  Congratulations to both new members.

• Avera Cancer Institute joins the Worldwide Innovation Network (WIN Consortium) focused on personalized cancer care.  Other members include MSK, as well as, New York University Langone Medical Center, University of Texas MD Anderson Cancer Center, and University of California San Diego Moores Cancer Center.

• Another article about drug cost!  Elizabeth D. Kantor, an assistant attending epidemiologist at MSK and her colleagues recently reported in a JAMA publication, trends in prescription drug use among adults in the United States from 1999 to 2012.

• Check out Synapse, MSK Publication database – discover recent works by MSK researchers, clinicians, nurses, and health care professionals!